Clinical Trial NCT02658981: Investigating Relatlimab for Recurrent Glioblastoma A multicenter, phase 1 clinical trial (NCT02658981), conducted under the NCI Adult Brain Tumor Consortium (ABTC), evaluated the safety and immunological impact …
Tag: